Sarah A. Hitchen
Perth, WA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Telehealth during COVID-19 restrictions in patients with cardiovascular disease: impact on medication prescriptions and patient satisfaction.
Journal: Internal medicine journal
Published: October 15, 2023
Barriers to prescribing proprotein convertase subtilisin-kexin type 9 inhibitors after coronary revascularisation.
Journal: Internal medicine journal
Published: November 09, 2021
Real-world barriers and safety of initiating sodium-glucose co-transporter 2 inhibitor treatment immediately following an acute cardiac event in people with diabetes.
Journal: Journal of diabetes and its complications
Published: July 22, 2021
Investigating the effect of an education programme on diabetes and lipid lowering medication usage following coronary artery bypass graft surgery.
Journal: Internal medicine journal
Published: November 26, 2020
Managing inpatient hyperglycaemia and initiating sodium-glucose cotransporter 2 inhibitor therapy in the setting of diabetes and acute coronary syndrome.
Journal: Internal medicine journal
Published: June 09, 2020
Priorities and practicalities of prescribing diabetes medicines with cardiovascular and renal protective effects: an Australian perspective.
Journal: Internal medicine journal
Published: April 17, 2020
The role of a Coronavirus disease 2019 pharmacist: an Australian perspective.
Journal: International journal of clinical pharmacy
Published: April 15, 2020
Short-term outcomes following coronary artery bypass graft surgery in insulin treated and non-insulin treated diabetes: A tertiary hospital experience in Australia.
Journal: Diabetes & metabolic syndrome
Published: October 25, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026